*Relapse defined as endoscopic erosions and/or recurrent symptoms leading to patient-initiated withdrawal from the study.
†Data from a multicenter, randomized, double-blind, parallel-group, 6-month trial comparing oral doses of NEXIUM 20 mg with lansoprazole 15 mg administered once daily in patients with endoscopically confirmed healed EE with NEXIUM 40 mg.1,2
‡Varying grades of EE defined as LA grades A, B, C, and D erosive esophagitis.1,2
1. Lauritsen K, Devière J, Bigard M-A, et al. Aliment Pharmacol Ther. 2003;17:333–341.
2. Data on file, eSTaR #268101.
3. DeVault KR, Johanson JF, Johnson DA, et al. Clin Gastroenterol Hepatol. 2006;4:852–859.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.